首页> 美国卫生研究院文献>Frontiers in Microbiology >Antibiotics as selectors and accelerators of diversity in the mechanisms of resistance: from the resistome to genetic plasticity in the β-lactamases world
【2h】

Antibiotics as selectors and accelerators of diversity in the mechanisms of resistance: from the resistome to genetic plasticity in the β-lactamases world

机译:抗生素作为抗药性机制中多样性的选择者和促进剂:从抗药性到β-内酰胺酶世界的遗传可塑性

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Antibiotics and antibiotic resistance determinants, natural molecules closely related to bacterial physiology and consistent with an ancient origin, are not only present in antibiotic-producing bacteria. Throughput sequencing technologies have revealed an unexpected reservoir of antibiotic resistance in the environment. These data suggest that co-evolution between antibiotic and antibiotic resistance genes has occurred since the beginning of time. This evolutionary race has probably been slow because of highly regulated processes and low antibiotic concentrations. Therefore to understand this global problem, a new variable must be introduced, that the antibiotic resistance is a natural event, inherent to life. However, the industrial production of natural and synthetic antibiotics has dramatically accelerated this race, selecting some of the many resistance genes present in nature and contributing to their diversification. One of the best models available to understand the biological impact of selection and diversification are β-lactamases. They constitute the most widespread mechanism of resistance, at least among pathogenic bacteria, with more than 1000 enzymes identified in the literature. In the last years, there has been growing concern about the description, spread, and diversification of β-lactamases with carbapenemase activity and AmpC-type in plasmids. Phylogenies of these enzymes help the understanding of the evolutionary forces driving their selection. Moreover, understanding the adaptive potential of β-lactamases contribute to exploration the evolutionary antagonists trajectories through the design of more efficient synthetic molecules. In this review, we attempt to analyze the antibiotic resistance problem from intrinsic and environmental resistomes to the adaptive potential of resistance genes and the driving forces involved in their diversification, in order to provide a global perspective of the resistance problem.
机译:抗生素和抗生素抗性决定簇是与细菌生理学密切相关且与古代起源一致的天然分子,不仅存在于产生抗生素的细菌中。吞吐量测序技术揭示了环境中意想不到的抗生素耐药性。这些数据表明,自从开始以来,就已经在抗生素和抗生素抗性基因之间发生了共同进化。由于高度调控的过程和低抗生素浓度,这种进化种族可能一直很慢。因此,要了解这个全球性问题,必须引入一个新变量,即抗生素耐药性是生命固有的自然事件。然而,天然和合成抗生素的工业化生产极大地加速了这场竞赛,从自然界中存在的许多抗性基因中选择了一些,并促进了其多样化。 β-内酰胺酶是可用来了解选择和多样化对生物的影响的最佳模型之一。它们构成了抗药性最广泛的机制,至少在致病细菌中,已有文献中鉴定出1000多种酶。近年来,人们越来越关注在质粒中具有碳青霉烯酶活性和AmpC型的β-内酰胺酶的描述,传播和多样化。这些酶的系统发生学有助于理解驱动其选择的进化力。此外,了解β-内酰胺酶的适应性潜力有助于通过设计更有效的合成分子来探索进化拮抗剂的轨迹。在这篇综述中,我们试图分析抗生素抗药性问题,从固有的和环境的抗药性到抗药性基因的适应潜力以及涉及其多样化的驱动力,以便为抗药性问题提供一个全球视角。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号